3 RESULTS 3.1 Selecting appropriate patients for self‐administration of C1‐INH(SC) Surveys of real‐life HAE treatment patterns (Aygören‐Pürsün, Martinez‐Saguer, Rusicke, Klingebiel, & Kreuz, 2010 ; Jolles et al., 2014 ; Riedl, 2015 ; Riedl et al., 2016 ) indicate an increasing trend towards self‐administration of HAE medications.
← all excerpts
Training patients for self-administration of a new subcutaneous C1-inhibitor concentrate for hereditary angioedema.
1
—
—